Sanctuary Advisors LLC bought a new stake in shares of ARK Genomic Revolution ETF (BATS:ARKG – Free Report) in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm bought 9,590 shares of the company’s stock, valued at approximately $222,000.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ARKG. Chris Bulman Inc acquired a new position in shares of ARK Genomic Revolution ETF in the second quarter worth $36,000. EverSource Wealth Advisors LLC acquired a new position in ARK Genomic Revolution ETF in the 1st quarter valued at about $49,000. Larson Financial Group LLC lifted its holdings in ARK Genomic Revolution ETF by 4,576.1% in the 2nd quarter. Larson Financial Group LLC now owns 3,320 shares of the company’s stock valued at $78,000 after purchasing an additional 3,249 shares in the last quarter. First Horizon Advisors Inc. lifted its holdings in ARK Genomic Revolution ETF by 9.4% in the 2nd quarter. First Horizon Advisors Inc. now owns 4,650 shares of the company’s stock valued at $109,000 after purchasing an additional 398 shares in the last quarter. Finally, SkyOak Wealth LLC boosted its stake in shares of ARK Genomic Revolution ETF by 14.2% during the 1st quarter. SkyOak Wealth LLC now owns 8,029 shares of the company’s stock worth $231,000 after purchasing an additional 1,000 shares during the last quarter.
ARK Genomic Revolution ETF Stock Up 1.8 %
BATS:ARKG opened at $24.78 on Monday. The firm has a fifty day moving average price of $25.45 and a 200 day moving average price of $25.24.
ARK Genomic Revolution ETF Profile
The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.
Recommended Stories
- Five stocks we like better than ARK Genomic Revolution ETF
- How to invest in marijuana stocks in 7 stepsĀ
- Is Spotify Stock Poised to Soar? Options Traders Think So
- What Is WallStreetBets and What Stocks Are They Targeting?
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- Stock Market Upgrades: What Are They?
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.